Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07361458 · ClinicalTrials.gov registry record · NA

Modex, a Cloud-based, Centralized Health Economic Model Marketplace to Reduce Costs and Enhance Equity in Cancer

A NA study of Cancer, sponsored by Arnold Consultancy & Technology.

Completed
Registry status
NA
Development phase
9
Enrollment target
1
Study location

NCT07361458: Completed NA study of Cancer, sponsored by Arnold Consultancy & Technology.

NCT07361458 is a NA study of Cancer that has completed, run by Arnold Consultancy & Technology. The registered enrollment target is 9 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT07361458, a NA study of Cancer, has completed, sponsored by Arnold Consultancy & Technology.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

The investigators intend to create and test an interactive prototype of an online health economic model platform, ModEx™ (renamed HModEx®), to house oncology models. The primary objective is to create the HModEx® health economic model platform. The secondary objective is to conduct usability testing of search, quality and collaboration on the HModEx® prototype for 20 oncology health economic models with expert advisory panel participants.

Primary Outcome

Iteratively unit test 4 tasks (A) Revise model platform and back end, (B) Refine the model taxonomy/characterization (i.e., ontology) and search module, (C) Revamp submission module, and (D) Implement paid modules) individually to ascertain 100% pass of common functionality (e.g., searching, uploading, and evaluating models) in the system back end and then iteratively perform integration testing via the front-end user interface until 100% pass using the System Usability Scale. The overall value

Conditions Studied

Cancer

Interventions

  • OTHER open source health economic models

Study Locations (1)

Florida

  • Arnold Consultancy & Technology, LLC - Miami Beach

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2024-12-01
Est. Completion 2025-11-20
Phase NA
Arnold Consultancy & Technology

1 total trials

What the finished NCT07361458 record still lists

NCT07361458 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which open source health economic models is the first listed.

NCT07361458 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT07361458 about?

NCT07361458 is a clinical study titled "Modex, a Cloud-based, Centralized Health Economic Model Marketplace to Reduce Costs and Enhance Equity in Cancer". The investigators intend to create and test an interactive prototype of an online health economic model platform, ModEx™ (renamed HModEx®), to house oncology models. The primary objective is to create the HModEx® health economic model platform. The secondary objective is to conduct usability testing...

What is the current status of trial NCT07361458?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2024-12-01. Estimated completion is 2025-11-20.

What conditions does trial NCT07361458 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT07361458?

The interventions under investigation include: open source health economic models (OTHER).

Who is sponsoring clinical trial NCT07361458?

This trial is sponsored by Arnold Consultancy & Technology, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07361458 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07361458's enrollment target sits among peer trials

9 607th of 615 higher than 8 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT07361458, the US trial registry maintained by the National Library of Medicine. NCT07361458 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.